FEZZA, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 21.640
AS - Asia 2.143
EU - Europa 1.824
SA - Sud America 319
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 31
OC - Oceania 6
Totale 26.092
Nazione #
US - Stati Uniti d'America 21.531
SG - Singapore 1.007
CN - Cina 435
IT - Italia 316
RU - Federazione Russa 274
BR - Brasile 261
UA - Ucraina 258
DE - Germania 225
HK - Hong Kong 204
IE - Irlanda 184
VN - Vietnam 154
FR - Francia 120
SE - Svezia 102
BD - Bangladesh 98
GB - Regno Unito 96
PL - Polonia 95
FI - Finlandia 61
KR - Corea 61
JP - Giappone 60
CA - Canada 49
IN - India 29
MX - Messico 23
AR - Argentina 21
BE - Belgio 16
ES - Italia 15
CZ - Repubblica Ceca 13
JM - Giamaica 13
NL - Olanda 13
ZA - Sudafrica 13
EC - Ecuador 12
CR - Costa Rica 8
ID - Indonesia 8
IQ - Iraq 8
TR - Turchia 8
VE - Venezuela 8
CO - Colombia 7
PH - Filippine 7
EU - Europa 6
HU - Ungheria 6
IL - Israele 6
IR - Iran 6
KG - Kirghizistan 6
TH - Thailandia 6
AU - Australia 5
MY - Malesia 5
AT - Austria 4
GR - Grecia 4
JO - Giordania 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
CL - Cile 3
GT - Guatemala 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
OM - Oman 3
PK - Pakistan 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BS - Bahamas 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HN - Honduras 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
EG - Egitto 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MQ - Martinica 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
Totale 25.969
Città #
Woodbridge 5.873
Wilmington 5.458
Houston 4.722
Fairfield 674
Singapore 630
Ann Arbor 481
Ashburn 443
Chandler 370
San Jose 292
Seattle 274
Jacksonville 247
Cambridge 223
Hong Kong 198
Beijing 183
Dublin 180
Medford 145
Dearborn 121
Santa Clara 108
Los Angeles 99
Council Bluffs 97
New York 95
Kraków 78
The Dalles 76
Lawrence 66
Rome 57
Ho Chi Minh City 50
Tokyo 50
Hanoi 45
Moscow 39
Mülheim 39
Buffalo 37
Dallas 34
San Diego 31
Milan 29
Menlo Park 28
Munich 28
Lauterbourg 26
São Paulo 26
Chicago 21
Washington 18
Atlanta 17
Phoenix 17
Boardman 16
Brussels 16
London 16
San Mateo 16
Warsaw 15
Montreal 13
Naples 13
Orem 13
Chennai 12
Verona 12
Brno 11
Toronto 11
Zhengzhou 11
Brooklyn 10
Columbus 10
Nuremberg 10
Johannesburg 9
Kingston 9
Redondo Beach 9
Redwood City 9
San Francisco 9
Boston 8
Charlotte 8
Frankfurt am Main 8
Hefei 8
Saint Augustine 8
Seoul 8
Shanghai 8
Cagliari 7
Curitiba 7
Falls Church 7
Kunming 7
Mexico City 7
Nanjing 7
Poplar 7
Rio de Janeiro 7
Saint Petersburg 7
Denver 6
Detroit 6
Fortaleza 6
Palo Alto 6
San José 6
Bari 5
Berlin 5
Bologna 5
Cangzhou 5
Catania 5
Da Nang 5
Guangzhou 5
Guayaquil 5
Haiphong 5
Helsinki 5
North Bergen 5
Tucson 5
University Park 5
Amman 4
Auburn Hills 4
Baghdad 4
Totale 22.201
Nome #
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase 543
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity 524
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake 512
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction 500
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 500
Mouse blastocyts release a lipid which activates anandamide hydrolase in intact uterus 491
Endocannabinoids, related compounds and their metabolic routes 481
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins 480
The anandamide membrane transporter and the therapeutic implications of its inhibition 479
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid 478
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 477
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. 475
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. 471
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 470
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. 468
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol 467
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation 458
Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone 455
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 449
Evidence for the intracellular accumulation of anandamide in adiposomes 447
Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system 447
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 446
New insights into endocannabinoid degradation and its therapeutic potential 445
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 445
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. 445
Levels of N-Acylethanolamines in Human Tumors: In Search of Reliable Data 444
Methods to assay anandamide hydrolysis and transport in synaptosomes. 444
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 443
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 441
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. 440
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. 438
Endocannabinoids and their involvement in the neurovascular system. 438
Endocannabinoid biochemistry: What do we know after 50 years? 438
Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. 434
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 431
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. 430
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. 429
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17 beta-estradiol 428
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 428
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes 423
Pitfalls and solutions in assaying anandamide transport in cells. 418
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus 417
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 415
The endocannabinoid system in neurodegeneration. 411
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis 407
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 406
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 400
Rat and human fatty acid amide hydrolases: overt similarities and hidden differences. 397
null 393
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells 389
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism 381
Regulation of endocannabinoid system by lipid rafts along the neuroimmune axis 293
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 279
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 242
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 201
The endocannabinoid hydrolase FAAH is an allosteric enzyme 186
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 170
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 170
Assay of NAPE-PLD Activity 157
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 143
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 137
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 132
Bisphenol A deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin B production 126
Plant-Derived and Endogenous Cannabinoids in Epilepsy 120
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs 116
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 101
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 101
Fatty acid amide hydrolase, anandamide, and neurological diseases 89
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 86
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 85
Radiometric Assay of NAPE-PLD Activity 80
Endocannabinoids and platelets - Signalling pathways 80
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 78
Endocannabinoids and platelets - Differentiation 59
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 45
Totale 26.092
Categoria #
all - tutte 61.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022526 0 0 0 22 18 44 36 19 52 74 45 216
2022/2023930 108 82 45 123 70 203 61 59 83 4 68 24
2023/2024230 37 11 11 17 18 55 6 9 10 3 13 40
2024/20251.462 74 348 194 90 25 111 127 72 105 116 133 67
2025/20262.625 213 122 291 205 282 85 314 334 266 191 217 105
2026/2027926 212 101 483 130 0 0 0 0 0 0 0 0
Totale 26.092